Clinical Implications of Additional Mutations Detected by Next-Generation Sequencing in EGFR-Mutant Lung Adenocarcinoma

被引：0
|
作者：
Kadauke, S. [1 ]
Hiemenz, M. C. [1 ]
Deshpande, C. [1 ]
Litzky, L. A. [1 ]
Roth, D. B. [1 ]
Ahmed, S. [1 ]
Aggarwal, C. [1 ]
Morrissette, J. [1 ]
机构：
[1] Univ Penn Hlth Syst, Philadelphia, PA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2014年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST60
引用
收藏
页码：759 / 759
页数：1
相关论文
共 50 条
  • [1] Detection of sensitizing and resistance EGFR mutations from circulating tumor DNA (ctDNA) in blood using multiplexed next-generation sequencing in patients with advanced EGFR-mutant lung adenocarcinoma
    Goldberg, Sarah B.
    Narayan, Azeet
    Carriero, Nicholas J.
    Nemati, Roxanne
    Bommakanti, Ananth
    Wurtz, Anna
    Boffa, Daniel J.
    Decker, Roy H.
    Herbst, Roy S.
    Juergensmeier, Juliane M.
    Politi, Katerina A.
    Gettinger, Scott N.
    Patel, Abhijit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Next-Generation Sequencing in the Exploration of Genetic Heterogeneity for Lung Adenocarcinoma Patients with EGFR Activating Mutations
    Jin, Y.
    Shi, X.
    Chen, M.
    Fan, Y.
    Yu, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S477 - S477
  • [3] Impact of next-generation sequencing on clinical outcomes in advanced EGFR-mutant lung cancer patients after resistance to osimertinib.
    Cheng, Jia-Tao
    Yang, Jin-Ji
    Wu, Yi-Long
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing
    Xiaoyun Zhou
    Xiaohui Xu
    Zhenhuan Tian
    Wang-Yang Xu
    Yushang Cui
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2277 - 2287
  • [5] Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing
    Zhou, Xiaoyun
    Xu, Xiaohui
    Tian, Zhenhuan
    Xu, Wang-Yang
    Cui, Yushang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2277 - 2287
  • [6] Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma
    Bria, Emilio
    Pilotto, Sara
    Amato, Eliana
    Fassan, Matteo
    Novello, Silvia
    Peretti, Umberto
    Vavala, Tiziana
    Kinspergher, Stefania
    Righi, Luisella
    Santo, Antonio
    Brunelli, Matteo
    Corbo, Vincenzo
    Giglioli, Eliana
    Sperduti, Isabella
    Milella, Michele
    Chilosi, Marco
    Scarpa, Aldo
    Tortora, Giampaolo
    [J]. ONCOTARGET, 2015, 6 (14) : 12783 - 12795
  • [7] Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations
    Kim, In Ae
    Hur, Jae Young
    Kim, Hee Joung
    Lee, Song Am
    Hwang, Jae Joon
    Kim, Wan Seop
    Lee, Kye Young
    [J]. CANCERS, 2021, 13 (14)
  • [8] Tackling the Next Generation of Resistance in EGFR-Mutant Lung Cancer
    Piotrowska, Zofia
    Sequist, Lecia V.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 419 - 421
  • [9] A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel
    Cimino, Patrick J.
    Bredemeyer, Andy
    Abel, Haley J.
    Duncavage, Eric J.
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (03) : 568 - 573
  • [10] A Wide Spectrum of EGFR Mutations in Glioblastoma Is Detected By a Single Clinical Oncology Targeted Next-Generation Sequencing Panel
    Cimino, Patrick
    Abel, Haley
    Duncavage, Eric
    [J]. MODERN PATHOLOGY, 2015, 28 : 430A - 430A
12345